NeurAxis, Inc. (NRXS) AMEX
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
NeurAxis, Inc.
Address
11550 North Meridian Street
Carmel, IN 46032
United States of America (the)
Phone
(812) 689-0791
Website
Sector
Healthcare
Industry
Biotechnology
Employees
21
First IPO Date
August 09, 2023
Key Executives
| Name | Title | Pay | Year Born |
| Brian Carrico | President, Chief Executive Officer & Director | 547,598 | 1982 |
| Adrian Miranda | Senior Vice President of Science & Technology and Chief Medical Officer | 399,069 | 1970 |
| Thomas Carrico | Chief Regulatory Officer and Compliance & Privacy Officer | 400,575 | 1957 |
| Timothy Robert Henrichs | Chief Financial Officer | 489,423 | 1973 |
| Behnam Shamsian | Investor Relations | 0 | N/A |
| Christopher Robin Brown | Founder, Director of Innovation & Director | 0 | 1954 |
Description
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
